Home > Drug Search >
  • company_query: Agios Pharmaceuticals
  •   > 
Drug Filter
Category:
chemistry (20) biology (3)
Status:
Approved (3) Phase Ⅲ (4) Phase Ⅱ (11) Phase Ⅰ (5)
Clinical Stage:
Pending (3) Active (11) Discontinued (6)
Bio-Type:
Blood extraction (1) Whole antibody (2)
Indication:
Actinic keratosis (AK) (1) Acute myeloid Leukemia (AML) (3) Alzheimer's disease (AD) (2) Amyotrophic lateral sclerosis (ALS) (2) Anemia (1) Atherosclerosis (1) Attention deficit hyperactivity disorder (ADHD) (1) Breast cancer (2) Candidiasis (1) Agammaglobulinaemia (1) Cognitive disorders (1) Colorectal neoplasms (2) Cutaneous fungal infections (1) Hypertension (1) Chronic inflammatory demyelinating polyradiculoneuropathy (1) Stevens-Johnson syndrome (1) Toxic epidermal necrolysis (1) Niemann-Pick diseases (1) Non-Hodgkin B-cell lymphomas (1) Non-Hodgkin’s lymphoma (NHL) (1) Pancreatic cancer (1) Parkinson's disease (PD) (1) Solid tumours (4) Diabetic foot ulcers (1) Cholangiocarcinoma (1) Trichophyton rubrum infection (1) Epidermophyton floccosum infection (1) Ringworm (1) Tinea versicolor (1) Diagnostic agents (1) Hematological cancer (1) Clear cell renal cell cancer (ccRCC) (1) Ischemic stroke (1) Glioma (1) Pyruvate kinase deficiency (1) Pemphigus vulgaris (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top